S
SRPT
Sarepta Therapeutics Inc
22.26
-0.56-2.45%After Hours: 22.28 +0.02 +0.09%19:54 12/05 EST
OPEN/PREV CLOSE22.89/22.82
TODAY RANGE21.95-22.93
VOL2.66M
MARKET CAP2.33B
52 WEEK RANGE10.42-132.65
AVG VOL (3M)5.53M
% TURNOVER2.54%
TURNOVER--
P/E (TTM)-6.9833
% RANGE4.32%
EPS(TTM)-3.1876
P/E(FORWARD)-3.7986
P/B1.767
BVPS12.60
DIVIDEND--
P/S1.134
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.22B
SHARES OUTSTANDING104.79M
NEXT EARNINGS02/24-03/02
FREE FLOAT99.91M
LOT SIZE1
EX-DATE07/12/2012
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
Sarepta Therapeutics (SRPT): Valuation Check After New ENDEAVOR Dosing Approval and SRP-1003 Pipeline Milestones
Benzinga·3d ago
Solid Biosciences: Better Positioned To Compete In DMD Gene Therapy, Says Bullish Analyst
Simply Wall St·3d ago
There's No Escaping Sarepta Therapeutics, Inc.'s (NASDAQ:SRPT) Muted Revenues Despite A 35% Share Price Rise
Simply Wall St·6d ago
Did FDA Green Light for ELEVIDYS and Pipeline Progress Just Shift Sarepta Therapeutics' (SRPT) Narrative?
Benzinga·6d ago
Silver Soars Past $58, Bitcoin-Strategy Bloodbath Deepens: What's Moving Markets Monday?
Simply Wall St·11/29 11:15
Sarepta Therapeutics (SRPT): Evaluating Valuation After FDA Progress and Pipeline Milestones
Simply Wall St·11/27 13:20
Is Sarepta Therapeutics a Bargain After FDA Approval and Last Week's 27.8% Rally?
Seeking Alpha·11/27 12:20
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
Benzinga·11/26 18:31
Tech Stocks Surge Ahead Of Thanksgiving, Robinhood Rallies 10%: What's Moving Markets Wednesday?
TipRanks·11/26 12:28
Sarepta Therapeutics (SRPT) Gets a Buy from Wells Fargo
NASDAQ·11/25 18:08
Sarepta's Stock Rises on Positive Updates on DM1 Therapy
Benzinga·11/25 17:07
Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk
Same Industry
Name/Symbol
Change%
Price